Adhesion Barrier Market – Johnson & Johnson acquires a global pharmaceutical company.

Recent Developments

Johnson & Johnson is an American Multinational medical device, pharmaceutical, and consumer packaged goods manufacturing company. Johnson & Johnson provides Adhesion barriers which are real films, fabrics, gels or other materials that are applied between layers of tissues at the end of the surgery before the incision site is closed.

On September 2018, Johnson & Johnson Medical GmbH acquired Emerging Implant Technologies GmbH, the manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery.

To know more, read @

Market Overview:

Adhesion Barrier Market worth was around USD 954.73 million in 2018 and estimated to be growing at higher CAGR of 8.4%, to reach USD 1428.98 million by 2023.

Report segmented as

By Product:

  • Synthetic Adhesion Barriers
  • Natural Adhesion Barriers

By Application:

  • Gynecological
  • Cardiovascular
  • Neurological
  • Orthopedic
  • General/Abdominal
  • Urological
  • Reconstructive Surgeries

Increasing geriatric population, rising incidences of sports-related Hand & Wrist injuries and increasing funding for R&D to make novel and innovative products. Presence of alternative surgical techniques, which are minimally invasive, is going to hinder the growth of the market.

Geographical Segmentation:

Based on geography, the market is analyzed under many countries namely North America, Asia-Pacific, Europe, Latin America and the Middle East and Africa. North America is leading the market due to the highly developed healthcare infrastructure.

Key market players:

  • Medtronic Plc.
  • Johnson & Johnson
  • R. Bard (US)
  • Innocoll Holdings (Ireland)
  • BMI Korea Co. (South Korea)
  • MAST Biosurgery AG.
  • Integra Lifesciences Corporation
  • Anika Therapeutics (US)
  • FzioMed (US)
  • Sanofi (France)
  • Baxter International (US)
  • Integra LifeSciences (US)
  • Aziyo Biologics (US)
  • Atrium Medical Corporation (US)
  • Betatech Medical (Turkey)
  • SyntheMed (US)
  • Biom’up (France)
  • Terumo Corporation (Japan)

View a sample and decide @

The Scope of the report:

The report offers a comprehensive examination of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in influencing the market dynamics and trends discussed in detail at the product level. Further, the performance of the market at the regional and country-level had assessed, and the prospects with huge growth potential identified and debated.

The key players in the industry are profiled giving insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry had provided. The report also provides a broad outlook of the current market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:   

Abhishek Shukla

Sales Manager at Market Data Forecast


Tel: +1-888-702-9626


Be the first to comment

Leave a Reply

Your email address will not be published.